Usefulness of written information in treatment choice for men with low-risk prostate cancer
Intended for healthcare professionals
Art & Science Previous     Next

Usefulness of written information in treatment choice for men with low-risk prostate cancer

Claire Parker Urology cancer nurse specialist, Aintree University Hospital NHS Foundation Trust, Liverpool
Maria Flynn Head of postgraduate studies, School of Health Sciences, University of Liverpool

Claire Parker and Maria Flynn evaluate whether written information is a priority for men with low-risk prostate cancer in their active surveillance treatment plan

Active surveillance (AS) is a treatment option offered to men with low-risk prostate cancer, as an alternative to other radical curative interventions. AS involves regular consultations, digital rectal examinations and repeat biopsies, and men need to be given relevant and accessible information to help them make an informed choice about their treatment plan. In an NHS trust, AS has been offered for several years, yet it is not known whether the written information that is given to men at diagnosis is useful to them. In the context of patients being active participants in their care, it is important to review the ways in which we disseminate information to help people make treatment choices. This small evaluation was designed to explore men’s views of the usefulness of written information in their decision making about treatment options for low-risk prostate cancer. Data were collected through semi-structured interviews, and interview transcripts were thematically coded.

Findings suggest that written information is less useful to men than clinical consultations, which may have implications for the ways in which we involve and support men with prostate cancer in making their treatment decisions.

Cancer Nursing Practice. 15, 4, 23-27. doi: 10.7748/cnp.15.4.23.s19

Correspondence

claire.parker@aintree.nhs.uk

Peer review

This article has been subject to double-blind review and checked using antiplagiarism software

Conflict of interest

None declared

Received: 10 March 2016

Accepted: 15 April 2016

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more